Eli Lilly plans to acquire Centessa Pharmaceuticals, which has been conducting a midstage clinical trial of its lead drug.
Eli Lilly Will Buy a Narcolepsy Drug Developer for $6.3 Billion
Originally reported by New York Times
Related Articles
Haggling prices and chasing debts - tradespeople hit with cost of living headache
Haggling prices and chasing debts - tradespeople hit with cost of living headache10 minutes agoShareSaveAdd as preferred...
Full nationalisation of British Steel expected in King’s speech
Officials reportedly drafting legislation likely to safeguard Britain’s last blast furnaces and save thousands of jobs T...
Trump tariff refunds are actually happening – and businesses should pay attention
Business owners may have to wade through paperwork, but the US government is now processing refundsWhen the supreme cour...
‘Degree of complacency’: are supply chains prepared for impact of ongoing Iran war?
The economic warnings are bleak, but full extent of shortages are still not felt for many European countriesThe biggest ...